相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies
Manuela Di Fusco et al.
EXPERT REVIEW OF VACCINES (2022)
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis
Alexandre R. Marra et al.
JOURNAL OF INFECTION (2022)
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States
Mark W. Tenforde et al.
CLINICAL INFECTIOUS DISEASES (2022)
Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada
Danuta M. Skowronski et al.
CLINICAL INFECTIOUS DISEASES (2022)
Covid-19 vaccine immunogenicity in people living with HIV-1
Lauriane Nault et al.
VACCINE (2022)
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
Zabrina L. Brumme et al.
NPJ VACCINES (2022)
Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes
Sarah A. Buchan et al.
JAMA NETWORK OPEN (2022)
Sputnik V protection from COVID-19 in people living with HIV under antiretroviral therapy
Vladimir A. Gushchin et al.
ECLINICALMEDICINE (2022)
Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019
Dima Dandachi et al.
CLINICAL INFECTIOUS DISEASES (2021)
Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa
Andrew Boulle et al.
CLINICAL INFECTIOUS DISEASES (2021)
People living with HIV easily lose their immune response to SARS-CoV-2: result from a cohort of COVID-19 cases in Wuhan, China
Yanbin Liu et al.
BMC INFECTIOUS DISEASES (2021)
HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform
Krishnan Bhaskaran et al.
LANCET HIV (2021)
Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study
Erjia Ge et al.
PLOS ONE (2021)
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study
Daniel K. Nomah et al.
LANCET HIV (2021)
Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data
Xueying Yang et al.
LANCET HIV (2021)
Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis
Paddy Ssentongo et al.
SCIENTIFIC REPORTS (2021)
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
Itzchak Levy et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study
Hannah Chung et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Evaluating the Utility of Coarsened Exact Matching for Pharmacoepidemiology Using Real and Simulated Claims Data
John E. Ripollone et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2020)
The Use of Test-negative Controls to Monitor Vaccine Effectiveness A Systematic Review of Methodology
Huiying Chua et al.
EPIDEMIOLOGY (2020)
Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets
Naveed Zafar Janjua et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2018)
Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness
Sheena G. Sullivan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants
Naveed Zafar Janjua et al.
PLOS ONE (2016)
The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials
G De Serres et al.
Eurosurveillance (2013)
Application and Validation of Case-Finding Algorithms for Identifying Individuals with Human Immunodeficiency Virus from Administrative Data in British Columbia, Canada
Bohdan Nosyk et al.
PLOS ONE (2013)
The test-negative design for estimating influenza vaccine effectiveness
Michael L. Jackson et al.
VACCINE (2013)
Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research
Peter C. Austin
COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION (2009)